N. Ketterer

Discipline

Psychologie (1) Economies et finances (1)

Type de document

Articles (14) Recensions (3)

Co-auteur

Date

Source

Mot-clé

Treatment (11) Patients (11) Patients (11) Human beings (10) Chemotherapy (9) Lymphomas (9) Chemotherapy (9) thérapie (7) survie (7) Therapeutics (7) Survival (7) Older people (7) taux (5) temps (durée) (4) maladie (4) Diagnosis (4) Time (4) Months (4) Management (4) Diagnosis (4) Use (4) maladie (4) administration (3) puits (3) adulte (3) procès (3) Methods (3) Cases (3) Radioimmunotherapy (3) Tumors (3)

Documents écrit par N. Ketterer (14) | parle de N. Ketterer (0)

Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
E. Poullot et al.
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
C. Bonnet et al. (1 juin 2023)
Kommt eine niedrig dosierte Radiotherapie (2 × 2 Gy) bei primären bilateralen follikulären Bindehaut-Lymphom infrage? [Can Low Dose Radiation Therapy (2 × 2 Gy) be Used in Primary Bilateral Conjunctival Follicular Lymphoma?]
S. Cotting-Bodmer et al.
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
P. Samaras et al. (2015)
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).
N. Ketterer et al. (2013)
Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
F. Buchegger et al. (2013)
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.
C. Renner et al. (2012)
Diagnosis and treatment of follicular lymphoma.
F. Hitz et al. (2011)
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations.
C. Taverna et al. (2010)
Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
V. Frossard et al. (2009)
Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma.
F. Buchegger et al. (2006)
Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics.
C. Antonescu et al. (2005)
Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization?
J. Delaloye et al. (2004)
Sequential high-dose combination chemotherapy with granulocyte colony-stimulating factor and peripheral blood progenitor cells in patients with solid tumors: intensification limited by nonhematologic toxic effects
S. Leyvraz et al.